US Stock MarketDetailed Quotes

MIST Milestone Pharmaceuticals

Watchlist
  • 1.410
  • -0.020-1.40%
Close Jun 14 16:00 ET
75.10MMarket Cap-1128P/E (TTM)

Milestone Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
-80.00%1M
0
0
0
1M
-66.67%5M
3.5M
1.5M
0
Operating revenue
--0
-80.00%1M
--0
--0
--0
--1M
-66.67%5M
--3.5M
--1.5M
--0
Cost of revenue
Gross profit
Operating expense
-36.52%10.48M
-3.94%62.1M
-20.04%13.8M
-7.08%15.36M
-2.20%16.44M
17.48%16.5M
11.31%64.64M
2.02%17.26M
15.81%16.53M
17.62%16.81M
Selling and administrative expenses
9.48%6.84M
25.12%31.05M
24.95%8.35M
28.86%8.64M
27.08%7.81M
18.30%6.25M
27.89%24.81M
11.31%6.68M
47.67%6.7M
26.50%6.15M
-Selling and marketing expense
22.41%2.88M
66.18%15.11M
94.57%4.98M
65.24%4.41M
51.01%3.37M
44.01%2.36M
29.87%9.1M
15.49%2.56M
69.09%2.67M
21.05%2.23M
-General and administrative expense
1.65%3.95M
1.36%15.93M
-18.24%3.37M
4.78%4.23M
13.45%4.45M
6.75%3.89M
26.77%15.72M
8.87%4.12M
36.24%4.03M
29.82%3.92M
Research and development costs
-64.52%3.64M
-22.04%31.05M
-48.46%5.45M
-31.60%6.72M
-19.10%8.62M
16.98%10.26M
2.99%39.83M
-3.10%10.58M
0.96%9.83M
13.05%10.66M
Operating profit
32.42%-10.48M
-2.44%-61.1M
-0.30%-13.8M
-2.20%-15.36M
2.20%-16.44M
-10.36%-15.5M
-38.47%-59.64M
18.67%-13.76M
-5.30%-15.03M
-2,460.39%-16.81M
Net non-operating interest income expense
-77.90%122K
12.68%1.41M
-67.53%189K
-41.14%279K
148.73%393K
1,280.00%552K
470.00%1.25M
1,611.76%582K
887.50%474K
172.41%158K
Non-operating interest income
69.91%994K
216.35%3.97M
79.73%1.05M
136.29%1.12M
667.72%1.21M
1,362.50%585K
470.00%1.25M
1,611.76%582K
887.50%474K
172.41%158K
Non-operating interest expense
2,542.42%872K
--2.55M
--857K
--841K
--820K
--33K
--0
--0
--0
--0
Other net income (expense)
Income before tax
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
-2.33%-14.56M
-2,262.08%-16.65M
Income tax
Net income
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
-2.33%-14.56M
-2,262.08%-16.65M
Net income continuous Operations
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
-2.33%-14.56M
-2,262.08%-16.65M
Minority interest income
Net income attributable to the parent company
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
-2.33%-14.56M
-2,262.08%-16.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
-2.33%-14.56M
-2,262.08%-16.65M
Basic earnings per share
40.00%-0.21
-0.72%-1.39
-3.23%-0.32
-2.94%-0.35
5.13%-0.37
-6.06%-0.35
-35.29%-1.38
22.50%-0.31
0.00%-0.34
-2,050.00%-0.39
Diluted earnings per share
40.00%-0.21
-0.72%-1.39
-3.23%-0.32
-2.94%-0.35
5.13%-0.37
-6.06%-0.35
-35.29%-1.38
22.50%-0.31
0.00%-0.34
-2,050.00%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0-80.00%1M0001M-66.67%5M3.5M1.5M0
Operating revenue --0-80.00%1M--0--0--0--1M-66.67%5M--3.5M--1.5M--0
Cost of revenue
Gross profit
Operating expense -36.52%10.48M-3.94%62.1M-20.04%13.8M-7.08%15.36M-2.20%16.44M17.48%16.5M11.31%64.64M2.02%17.26M15.81%16.53M17.62%16.81M
Selling and administrative expenses 9.48%6.84M25.12%31.05M24.95%8.35M28.86%8.64M27.08%7.81M18.30%6.25M27.89%24.81M11.31%6.68M47.67%6.7M26.50%6.15M
-Selling and marketing expense 22.41%2.88M66.18%15.11M94.57%4.98M65.24%4.41M51.01%3.37M44.01%2.36M29.87%9.1M15.49%2.56M69.09%2.67M21.05%2.23M
-General and administrative expense 1.65%3.95M1.36%15.93M-18.24%3.37M4.78%4.23M13.45%4.45M6.75%3.89M26.77%15.72M8.87%4.12M36.24%4.03M29.82%3.92M
Research and development costs -64.52%3.64M-22.04%31.05M-48.46%5.45M-31.60%6.72M-19.10%8.62M16.98%10.26M2.99%39.83M-3.10%10.58M0.96%9.83M13.05%10.66M
Operating profit 32.42%-10.48M-2.44%-61.1M-0.30%-13.8M-2.20%-15.36M2.20%-16.44M-10.36%-15.5M-38.47%-59.64M18.67%-13.76M-5.30%-15.03M-2,460.39%-16.81M
Net non-operating interest income expense -77.90%122K12.68%1.41M-67.53%189K-41.14%279K148.73%393K1,280.00%552K470.00%1.25M1,611.76%582K887.50%474K172.41%158K
Non-operating interest income 69.91%994K216.35%3.97M79.73%1.05M136.29%1.12M667.72%1.21M1,362.50%585K470.00%1.25M1,611.76%582K887.50%474K172.41%158K
Non-operating interest expense 2,542.42%872K--2.55M--857K--841K--820K--33K--0--0--0--0
Other net income (expense)
Income before tax 30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M-2.33%-14.56M-2,262.08%-16.65M
Income tax
Net income 30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M-2.33%-14.56M-2,262.08%-16.65M
Net income continuous Operations 30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M-2.33%-14.56M-2,262.08%-16.65M
Minority interest income
Net income attributable to the parent company 30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M-2.33%-14.56M-2,262.08%-16.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M-2.33%-14.56M-2,262.08%-16.65M
Basic earnings per share 40.00%-0.21-0.72%-1.39-3.23%-0.32-2.94%-0.355.13%-0.37-6.06%-0.35-35.29%-1.3822.50%-0.310.00%-0.34-2,050.00%-0.39
Diluted earnings per share 40.00%-0.21-0.72%-1.39-3.23%-0.32-2.94%-0.355.13%-0.37-6.06%-0.35-35.29%-1.3822.50%-0.310.00%-0.34-2,050.00%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg